. 2011;31(10):721–731.
23. Filén S, Lahesmaa R. GIMAP proteins in T-lymphocytes. Journal of Signal Transduction. 2010; Article ID 268589, 10 pages. doi:10.1155/2010/268589.
24. Hygiene Hypothesis. http://www.hygienehypothesis.com/. Открыто 1 ноября 2012 г.
25. Zaletel K, Gaberscek S. Hashimoto’s thyroiditis: from genes to disease. Current Genomics. 2011;12:576–588.
26. Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 ratio in severe Hashimoto’s disease in the proportion of Th17 cells in intractable Graves’ disease. Thyroid. 2009;19(5).
27. CliffsNotes.com. Humoral and cell-mediated immune responses. http://www.cliffsnotes.com/study_guide/topicArticleId-277792,articleId-277723.html. Открыто 7 ноября 2012 г.
28. http://chriskresser.com/basics-of-immune-balancing-forhashimotos. Открыто 8 ноября 2012 г.
29. http://digitalnaturopath.com/cond/C104673.html. Открыто 8 ноября 2012 г.
30. http://www.easyhealthzone.com/autoimmune-diseases-s/30.htm. Открыто 8 ноября 2012 г.
31. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells determine whether Th1 or Th2 response patterns predominate. Proc Natl Acad Sci USA. Mar 17, 1998;95(6):3071–3076.
32. www.lowdosenaltrexone.org. Открыто 8 ноября 2012 г.
33. http://www.precisionnutrition.com/rr-green-tea-hazards. Открыто 8 ноября 2012 г.
34. http://wellnessalternatives-stl.blogspot.com/2012/05/am-i-th1-orth2-or-th17.html. Открыто 8 ноября 2012 г.
35. http://www.youtube.com/watch?v=LSYED-7riNY&feature=related. Открыто 8 ноября 2012 г.
36. http://articles.mercola.com/sites/articles/archive/2009/03/14/Clearing-up-Confusion-on-Vitamin-D-Why-I-Dont-Recommendthe-Marshall-Protocol.aspx.
37. Shoji J, Inada N, Sawa M. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn J Ophthalmol. May – Jun 2006;50(3):195–204.
38. Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid. 2011;21(8).
39. Sherry, et al. Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through upregulation of IL-4 and Th2 polarization. Brain Behav Immun. May 2010;24(4):631–640.
40. Anatabine Investigator’s Information. Rock Creek Pharmaceuticals; June 2012. www.anatabloc.com. Открыто 15 марта 2013 г.
41. Gui J, Xiong F, Li J, Huang G. Effects of acupuncture on Th1, Th2 cytokines in rats of implantation failure. Evidence-Based Complementary and Alternative Medicine. 2012;2012.
42. Chang-cai X, Neng-Gui X, Yi-Xu D. Effect of acupuncture on Th1/Th2 cytokine balance in guinea pigs with allergic reaction type IV. Journal of New Chinese Medicine. 2008;5.
43. Jurenka, JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141–153.
44. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infection and autoimmune disease, Clinical Microbiology Reviews. Jan 2006;80–94.
45. Vojdani A, Lambert J. The role of Th17 in neuroimmune disorders. Target for CAM therapy. Part II. Evidence-Based Complementary and Alternative Medicine. 2011;1.
46. Shi Y, et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scandinavian Journal of Immunology. 72:250–255.
47. Patarka, R. Cytokines and chronic fatigue syndrome. Ann NY Acad Sci. Mar 2001;933:185–200.
Глава 11
1. Ulluwishewa, et al. Regulation of tight junction permeability by intestinal bacteria and dietary components. Journal of Nutrition. Mar 23, 2011.
2. Maes M, et al. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): Indication for the involvement of gram negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. Journal of Affective Disorders. 2007;99:237–240.
3. Maes M, Coucke F, Leunis JC. Normalization of increased translocation of endotoxin from gram-negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro Endocrinol Lett. 2007;28(6):739–744.
4. Maes M, Leunis JC. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gramnegative bacteria. Neuro Endocrinol Lett. Dec 2008;29(6):902–910.
5. El-Tawil AM. Zinc supplementation tightens leaky gut in Crohn’s disease. Inflamm Bowel Dis. Feb 2012;18(2):E399. doi: 10.1002/ibd.21926. Epub Oct 12, 2011. PMID: 21994075.
6. Lutgendorff F, Akkermans LM, Söderholm JD. The role of microbiota and probiotics in stress-induced gastrointestinal damage. Curr Mol Med. Jun 2008;8(4):282–298.
7. Maes M, Mihaylova I, De Ruyter M. Lower serum zinc in chronic fatigue syndrome (CFS): relationship to immune dysfunctions and relevance for the oxidative stress status in CFS. Journal of Affective Disorders. 2005.
8. Ulluwishewa D, et al. Regulation of tight junction permeability by intestinal bacteria and dietary components. Journal of Nutrition. 2011;141: 769–776.
9. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of Bifidobacteria in the human colon by oligofructose and inulin. Gastroentorology. 1995;108:975–982.
10. Fasano A. Leaky gut and autoimmune disease. Clin Rev Allergy Immunol. Feb 2012;42(1):71–78.
11. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. Jan 2011;91:151–175.
12. Patel RM, Myers LS, Kurundkar AR, Maheshwari A, Nusrat A, Lin PW. Probiotic bacteria induce maturation of intestinal claudin-3 expression and barrier function. Am J Pathol. Feb 2012;180(2):626–635.
13. Rapin JR, Wiernsperger N. Possible links between intestinal permeability and food processing: a potential therapeutic niche for glutamine. Clinics. 2010;65(6):635–643.
14. Vaarala O. Is the origin of type 1 diabetes in the gut? Immunol Cell Biol. Mar 2012;90(3):271–276.
15. Vaarala O, Atkinson MA, Neu J. The “Perfect Storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555–2562.
16. Campbell-McBride N. Gut and Psychology Syndrome. Halstan & Co. Ltd; 2010.
17. Gates, D. Body Ecology Diet. Hay House, Inc.; 2011.
18. Gibson GR, Macfarlane GT, Cummings JH. Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut. 1993;34:437–439.
19. http://bodyecology.com/articles/gut-permeability.php.
20. Kirpich, Irina A. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic tolllike receptor expression in a mouse model of alcoholic liver disease. Alcoholism, Clinical and Experimental Research. May 2012;36(5):835(0145–6008).
21. Wang, Hong-Bo. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein claudin-1 transcription. Digestive Diseases and Sciences. Jun 9, 2012;0163–2116.
22. Benjamin J, Makharia G, Ahuja V, Joshi YK. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn’s disease: a randomized controlled TrialDig. Dis Sci. 2012;57:1000–1012.
23. Campbell-McBride N. Food allergy. Journal of Orthomolecular Medicine. First Quarter, 2009;24(1):31–41. http://gaps.me/preview/?page_id=344.
24. Gottschall E. Breaking the Vicious Cycle: Intestinal Health Through Diet. The Kirkton Press; 1996.
25. Vermeulen MAR, de Jong J, Vaessen MJ, van Leeuwen PAM, Houdijk APJ. Glutamate reduces experimental intestinal hyperpermeability and facilitates glutamine support of gut integrity. World J Gastroenterol. Mar 2011;28;17(12):1569–1573.
26. Rao RK, Samak G. Role of glutamine in protection of intestinal epithelial tight junctions. Journal of Epithelial Biology and Pharmacology. 2012;5(Suppl 1-M7):47–54.
27. Pimentel M. Gut microbes and irritable bowel syndrome. IBS Centers for Educational Expertise, 2011.
28. Pimentel M, Mayer A, Park S, Chow E, Hasan A, Kong Y. Methane production during lactulose test is associated with gastrointestinal disease presentation. Digestive Diseases and Sciences. 2003;48(1):86–92.
29. Mori, K. Does the gut microbiota trigger Hashimoto’s disease? Discovery Magazine. Nov 2012.
30. Calcinaro F, Dionisi S, et al. Oral probiotic administration induces IL-10 production and prevents spontaneous autoimmune diabetes in no-obese diabetic mice. Diabetologia. 2005;48:1565–1575.
31. Kidd, PM. Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management. Alternative Medicine Review. 2011;6(6).
32. Vyasm U, Ranganathan N. Probiotics, prebiotics, and symbiotic: gut and beyond. Gastroenterology Research and Practice. 2012;Article ID 872716.
33. Daher, R, Yazbeck T, Jaoude JB, Abboud B. Consequences of dysthyroidism on the digestive tract and viscera. World J Gastroenterol. 2009; June 21:15(23):2834–2838.
34. Lakhan S, Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutrition and Metabolism. 2010;7:79.
35. Rozalski A. Potential virulence factors of Proteus bacilli. Journal of Microbiology and Molecular Biology